Lauri Kangas

Corporate Officer/Principal at Forendo Pharma Oy

Health Technology

Profile

Lauri Kangas is the founder of Hormos Medical Oy, which was founded in 1997.
He held the title of Principal from 2010 to 2011.
Currently, he is a Senior Adviser at Forendo Pharma Oy.

Lauri Kangas active positions

Companies	Position	Start
Forendo Pharma Oy Forendo Pharma Oy Pharmaceuticals: MajorHealth Technology Forendo Pharma Oy provides novel pharmaceutical treatments for endometriosis and low testosterone levels. Its product fispemifene is the first selective estrogen receptor modulator designed only for men, which helps for the treatment of symptoms of low testosterone, in phase II clinical studies in men with secondary hypogonadism; fispemifene has normalized the low testosterone levels. Its 17HSD1-inhibitor focuses on endometriosis, is a potent and selective lead compounds demonstrated in vivo proof of efficacy in disease model of endometriosis. The company was founded by Risto Arvo Sakari Lammintausta in 2013 and is headquartered in Turku, Finland.	Corporate Officer/Principal	-

All active positions of Lauri Kangas

Former positions of Lauri Kangas

Companies	Position	End
Hormos Medical Oy Hormos Medical Oy Pharmaceuticals: MajorHealth Technology Hormos Medical Oy discovers and develops novel hormonal therapies. It provides research and development of products to treat endocrine disorders associated with aging. The company was founded by Risto Arvo Sakari Lammintausta and Lauri Kangas in 1997 and is headquartered in Turku, Finland.	Founder	-

See the detail of Lauri Kangas's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Lauri Kangas's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Hormos Medical Oy Hormos Medical Oy Pharmaceuticals: MajorHealth Technology Hormos Medical Oy discovers and develops novel hormonal therapies. It provides research and development of products to treat endocrine disorders associated with aging. The company was founded by Risto Arvo Sakari Lammintausta and Lauri Kangas in 1997 and is headquartered in Turku, Finland.	Health Technology
Forendo Pharma Oy Forendo Pharma Oy Pharmaceuticals: MajorHealth Technology Forendo Pharma Oy provides novel pharmaceutical treatments for endometriosis and low testosterone levels. Its product fispemifene is the first selective estrogen receptor modulator designed only for men, which helps for the treatment of symptoms of low testosterone, in phase II clinical studies in men with secondary hypogonadism; fispemifene has normalized the low testosterone levels. Its 17HSD1-inhibitor focuses on endometriosis, is a potent and selective lead compounds demonstrated in vivo proof of efficacy in disease model of endometriosis. The company was founded by Risto Arvo Sakari Lammintausta in 2013 and is headquartered in Turku, Finland.	Health Technology